Teva Pharmaceutical Industries Ltd
Close on Oct 19, 2026Market cap $48.13BP/E 68.9Yield –
Teva Pharmaceutical Industries GAAP Gross Profit Margin by Quarter
GAAP Gross Profit Margin (%) (%)
Teva Pharmaceutical Industries GAAP Gross Profit Margin: 55.5% in Q3 2026, up 4.1 pts from a year earlier. That is the highest of the 15 quarters on record here.
Where the Q3 2026 figure comes from
“|| Gross profit margin | 55.5% | 51.4% | 52.4% | 50.1%”
Source: Form 8-K Earnings Release (0001171843-26-007054) ↗
Reported in SEC Form 10-K / Form 10-Q / Form 8-K Earnings Releases.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Teva Pharmaceutical Industries GAAP Gross Profit Margin (%), quarterly Q4 2021–Q3 2026 [Data set]. Compiled from Teva Pharmaceutical Industries SEC filings and investor materials. https://stockdatahq.com/stocks/teva/kpis/ng-gaap-gp-margin
See every metric in the Teva Pharmaceutical Industries KPI table. Data updated Nov 10, 2026.
See a number that looks wrong?